Extended-spectrum and CMY-type b-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain Y.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

High prevalence of azithromycin resistance to Treponema pallidum in geographically different areas in China X.-S. Chen, Y.-P. Yin, W.-H. Wei, H.-C. Wang,

R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T

Defining an extended-spectrum β-lactamase

Gut bacterial microbiota and obesity

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

M. R. Haverkate, T. N. Platteel, A. C. Fluit, J. W. Cohen Stuart, M. A

Evolution of extended-spectrum β-lactamases by mutation

Defining an extended-spectrum β-lactamase

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Assessing the residual antibacterial activity of clinical materials disinfected with glutaraldehyde, o-phthalaldehyde, hydrogen peroxide or 2-bromo-2-nitro-1,3-

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans? J.-Y. Madec, M. Haenni, P. Nordmann,

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia.

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Escherichia coli native valve endocarditis

A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals M. Nagao Clinical Microbiology and.

Vector control: a cornerstone in the malaria elimination campaign

Pharmacodynamics of doxycycline

J.P. Donnelly, B.E. De Pauw Clinical Microbiology and Infection

Abstracts cont. Clinical Microbiology and Infection

New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?

Training for the infectious diseases speciality in Norway

Isospora belli Clinical Microbiology and Infection

CMI editorial report 2011 Clinical Microbiology and Infection

Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin- clavulanate and piperacillin-tazobactam with extended-spectrum.

Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community R.E. Warren, G. Harvey, R. Carr, D. Ward,

C. Varela, A. Oliver, T.M. Coque, F. Baquero, R. Canton

Elements of design: the knowledge on which we build

The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study E. Manea, J. Sojo-Dorado, R.E. Jipa, S.N.

Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital L. Gibold, F. Robin, R.-N.

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case–control study M.

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López,

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Antibacterial drug discovery in the 21st century

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features A.

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Comparison of different methods for identification of species of the genus Raoultella: report of 11 cases of Raoultella causing bacteraemia and literature.

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

C. Gagliotti, L. Nobilio, M.L. Moro

Prevalence and diversity of extended-spectrum ß-lactamases in faecal Escherichia coli isolates from healthy humans in Spain L. Vinué, Y. Sáenz, S. Martínez,

R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T

I. Bitar, A. Piazza Clinical Microbiology and Infection

Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013 A. Badura, G. Feierl, G. Pregartner,

M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo

Results of two worldwide surveys into physician awareness and perceptions of extended-spectrum β-lactamases H. Goossens, S. Malhotra-Kumar, H. Eraksoy,

The atypical pneumonias: clinical diagnosis and importance

Predominance of SHV-5 β-lactamase in enteric bacteria causing community-acquired urinary tract infections in Bosnia and Herzegovina S. Uzunovic-Kamberovic,

Abstracts Clinical Microbiology and Infection

A. Ramette, J.M. Tiedje, A. Boetius

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

G. Kahlmeter Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Abstracts Clinical Microbiology and Infection

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Extended-spectrum and CMY-type b-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain Y. Doi, D.L. Paterson, P. Egea, A. Pascual, L. López-Cerero, M.D. Navarro, J.M. Adams-Haduch, Z.A. Qureshi, H.E. Sidjabat, J. Rodríguez-Baño Clinical Microbiology and Infection Volume 16, Issue 1, Pages 33-38 (January 2010) DOI: 10.1111/j.1469-0691.2009.03001.x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Distribution of extended-spectrum β-lactamase (ESBL)-producing or CMY-type β-lactamase (CMY)-producing Escherichia coli cases according to the place of acquisition at both study sites. Clinical Microbiology and Infection 2010 16, 33-38DOI: (10.1111/j.1469-0691.2009.03001.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Prevalence of extended-spectrum β-lactamase (ESBL)-producing or CMY-type β-lactamase (CMY)-producing Escherichia coli in retail meat at both sites. The retail chicken product with ESBL-producing E. coli in Pittsburgh also grew CMY-producing E. coli (*). Clinical Microbiology and Infection 2010 16, 33-38DOI: (10.1111/j.1469-0691.2009.03001.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions